Market Snapshot

S&P Futures
Dow Futures
NASDAQ Futures

Trillium Therapeutics Inc.   NASDAQ (TRIL)

17.67    $0.12   0.68%
At close   Monday, Oct 18 04:00 PM

Trillium Therapeutics Inc. Chart

TRIL Stock Price Today

Trillium Therapeutics Inc. (TRIL) stock rallied over 0.68% intraday to trade at $17.67 a share on NASDAQ. The stock opened with a gain of 0.17% at $17.58 and touched an intraday high of $17.75, rising 1.14% against the last close of $17.55. The stock went to a low of $17.51 during the session.

Stock Snapshot

17.55
Prev. Close
17.58
Open
2.31B
Market Cap
103.78M
Number of Shares
17.51
day Low
17.75
Day High
17.67
-
P/E ratio
10.01%
Free Float in %
-0.57
EPS (TTM)
2.91
Book Value per Share
2.51
Cash Flow per Share
657980
Volume

Trillium Therapeutics Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-10-18$$17.55$$747,842
2021-10-04$17.57$17.64$17.76$17.541,600,993
2021-10-01$17.84$17.56$17.81$17.462,311,734
2021-09-30$17.84$17.56$17.81$17.462,311,734
2021-09-10$17.37$17.29$17.37$16.911,992,527
2021-09-03$17.40$17.38$17.44$17.33222,090,000
2021-09-02$17.42$17.35$17.48$17.33193,340,000
2021-09-01$17.29$17.39$17.40$17.24190,200,000
2021-08-31$17.21$17.23$17.35$17.21245,410,000
2021-08-30$17.32$17.27$17.38$17.03314,840,000
2021-08-27$17.38$17.32$17.48$17.30525,890,000

Contact Details

2488 Dunwin Drive
Mississauga, ON L5L 1J9
Canada
http://trilliumtherapeutics.com
416 595 0627

About Company

Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Mississauga, Canada.

Frequently Asked Questions

What is the current Trillium Therapeutics Inc. (TRIL) stock price?

Trillium Therapeutics Inc. (NASDAQ: TRIL) stock price is $17.67 as of the last check on Monday, Oct 18. During the trading session, TRIL stock reached the peak price of $17.75 while $17.51 was the lowest point it dropped to.

TRIL's industry and sector of operation?

The NASDAQ listed TRIL is part of Biotechnology industry that operates in the broader Healthcare sector. Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer.

Who are the executives of TRIL?

Dr. Jan Skvarka
Pres, CEO & Director

Mr. James T. Parsons MAcc, CPA-CA
Chief Financial Officer

Dr. Robert Uger
Chief Scientific Officer

Dr. Penka Petrova
Chief Devel. Officer


What is the TRIL stock price today?

TRIL stock traded closed the last session at $17.67, which is $0.12 or 0.68% higher than its previous close of $17.55. TRIL's current trading price is -15.70% lower than its 52-week high of $20.96 where as its distance from 52-week low of $5.80 is 204.66%.

Link for TRIL official website?


How do I contact TRIL?

TRIL could be contacted at 2488 Dunwin Drive Mississauga, ON L5L 1J9 Canada, or at phone # 416 595 0627 and can also be accessed through its website: http://trilliumtherapeutics.com

How many shares of TRIL are traded daily?

TRIL stock volume for the day was 657980 shares while in the previous session number of TRIL shares traded was 747842. The average number of TRIL shares traded daily for last 3 months was 2.79M.

How much did TRIL change today?

The percentage change in TRIL stock occurred in the recent session was 0.68% while the dollar amount for the price change in TRIL stock was $0.12.

What price range TRIL stock been trading in?

In the recent session, the day high for TRIL stock was $17.75 while the low for TRIL stock touched on the day was $17.51.

What is the market cap of TRIL currently?

The market value of TRIL currently stands at $2.31B with its latest stock price at $17.67 and 103.78M of its shares outstanding.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam